Intestinal Ultrasound in Clinical Inflammatory Bowel Disease Care: From Diagnosis to Tight Monitoring
Author:
Open Access
- 1 November 2025
- journal article
- Published by The Korea Association of Clinical Ultrasound in Clinical Ultrasound
- Vol. 10 (2) , 75-81
Abstract
Intestinal ultrasound (IUS) has emerged as an essential imaging modality in inflammatory bowel disease (IBD), offering real-time, radiation-free assessment at the point of care. This review summarizes current evidence on practical techniques, diagnostic performance, and the expanding role of IUS in treat-to-target strategies. Standardized protocols incorporate bowel wall thickness, color Doppler signal, bowel wall stratification, and mesenteric fat assessment as core parameters. Meta-analyses demonstrate high sensitivity and specificity for detecting active inflammation in Crohn’s disease and ulcerative colitis, with IUS parameters correlating strongly with endoscopic disease activity scores. Validated scoring systems, including the International Bowel Ultrasound Segmental Activity Score, enhance standardization in clinical practice and trials. Beyond baseline assessment, IUS enables early therapeutic response monitoring, with bowel wall thickness reduction and Doppler normalization predicting favorable long-term outcomes including reduced hospitalization and surgery rates. IUS remission is associated with lower relapse risk compared with clinical response alone. Additionally, IUS provides unique advantages in specific clinical situations. As understanding of transmural inflammation deepens and training programs expand globally, IUS is positioned as a central tool for achieving deep, durable remission and optimizing long-term outcomes in IBD management.Keywords
This publication has 35 references indexed in Scilit:
- Global Training in Inflammatory Bowel Disease: Addressing Growing Challenges in IBDDigestive Diseases and Sciences, 2025
- IBUS‐SAS Is a Highly Accurate Intestinal Ultrasound Score for Predicting Endoscopic Disease Activity in Ulcerative ColitisUnited European Gastroenterology Journal, 2025
- AGA Clinical Practice Update on the Role of Intestinal Ultrasound in Inflammatory Bowel Disease: CommentaryClinical Gastroenterology and Hepatology, 2024
- Noninvasive Assessment of Postoperative Disease Recurrence in Crohn’s Disease: A Multicenter, Prospective Cohort Study on Behalf of the Italian Group for Inflammatory Bowel DiseaseClinical Gastroenterology and Hepatology, 2022
- Intestinal Ultrasound Is Accurate to Determine Endoscopic Response and Remission in Patients With Moderate to Severe Ulcerative Colitis: A Longitudinal Prospective Cohort StudyGastroenterology, 2022
- Early Ultrasound Response and Progressive Transmural Remission After Treatment With Ustekinumab in Crohn’s DiseaseClinical Gastroenterology and Hepatology, 2022
- Ultrasonography Tight Control and Monitoring in Crohn’s Disease During Different Biological Therapies: A Multicenter StudyClinical Gastroenterology and Hepatology, 2022
- Predictive value of Milan ultrasound criteria in ulcerative colitis: A prospective observational cohort studyUnited European Gastroenterology Journal, 2022
- Accuracy of Ultrasound for Evaluation of Colorectal Segments in Patients With Inflammatory Bowel Diseases: A Systematic Review and Meta-analysisClinical Gastroenterology and Hepatology, 2021
- STRIDE-II: An Update on the Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE) Initiative of the International Organization for the Study of IBD (IOIBD): Determining Therapeutic Goals for Treat-to-Target strategies in IBDGastroenterology, 2021